216 related articles for article (PubMed ID: 31519064)
1. Role of major facilitator superfamily transporter Qdr2p in biofilm formation by Candida glabrata.
Widiasih Widiyanto T; Chen X; Iwatani S; Chibana H; Kajiwara S
Mycoses; 2019 Dec; 62(12):1154-1163. PubMed ID: 31519064
[TBL] [Abstract][Full Text] [Related]
2. In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.
Kucharíková S; Neirinck B; Sharma N; Vleugels J; Lagrou K; Van Dijck P
J Antimicrob Chemother; 2015 Mar; 70(3):846-56. PubMed ID: 25406296
[TBL] [Abstract][Full Text] [Related]
3. Construction and Use of a Recyclable Marker To Examine the Role of Major Facilitator Superfamily Protein Members in
Vu BG; Moye-Rowley WS
mSphere; 2018; 3(2):. PubMed ID: 29600281
[No Abstract] [Full Text] [Related]
4. Transcriptional responses of
Alves R; Kastora SL; Gomes-Gonçalves A; Azevedo N; Rodrigues CF; Silva S; Demuyser L; Van Dijck P; Casal M; Brown AJP; Henriques M; Paiva S
NPJ Biofilms Microbiomes; 2020; 6():4. PubMed ID: 31993211
[No Abstract] [Full Text] [Related]
5. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H
J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087
[TBL] [Abstract][Full Text] [Related]
6. Expression of CgCDR1, CgCDR2, and CgERG11 in Candida glabrata biofilms formed by bloodstream isolates.
Song JW; Shin JH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
Med Mycol; 2009; 47(5):545-8. PubMed ID: 18651314
[TBL] [Abstract][Full Text] [Related]
7. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
8. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
9. Relative Abundances of Candida albicans and Candida glabrata in
Olson ML; Jayaraman A; Kao KC
Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422
[No Abstract] [Full Text] [Related]
10. Effects of fluconazole on Candida glabrata biofilms and its relationship with ABC transporter gene expression.
Fonseca E; Silva S; Rodrigues CF; Alves CT; Azeredo J; Henriques M
Biofouling; 2014; 30(4):447-57. PubMed ID: 24645630
[TBL] [Abstract][Full Text] [Related]
11. The Effectiveness of Voriconazole in Therapy of Candida glabrata's Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression.
Rodrigues CF; Gonçalves B; Rodrigues ME; Silva S; Azeredo J; Henriques M
Mycopathologia; 2017 Aug; 182(7-8):653-664. PubMed ID: 28439794
[TBL] [Abstract][Full Text] [Related]
12. Candida glabrata's recurrent infections: biofilm formation during Amphotericin B treatment.
Rodrigues CF; Silva S; Azeredo J; Henriques M
Lett Appl Microbiol; 2016 Aug; 63(2):77-81. PubMed ID: 27259377
[TBL] [Abstract][Full Text] [Related]
13. Adhesive and biofilm-forming Candida glabrata Lebanese hospital isolates harbour mutations in subtelomeric silencers and adhesins.
Fattouh N; Husni R; Finianos M; Bitar I; Khalaf RA
Mycoses; 2024 Jun; 67(6):e13750. PubMed ID: 38813959
[TBL] [Abstract][Full Text] [Related]
14. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the CgPDR16 gene attenuates azole tolerance and biofilm production in pathogenic Candida glabrata.
Culakova H; Dzugasova V; Perzelova J; Gbelska Y; Subik J
Yeast; 2013 Oct; 30(10):403-14. PubMed ID: 23939632
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
17. The effect of biomaterials and antifungals on biofilm formation by Candida species: a review.
Cuéllar-Cruz M; Vega-González A; Mendoza-Novelo B; López-Romero E; Ruiz-Baca E; Quintanar-Escorza MA; Villagómez-Castro JC
Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2513-27. PubMed ID: 22581304
[TBL] [Abstract][Full Text] [Related]
18. Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31.
Tati S; Jang WS; Li R; Kumar R; Puri S; Edgerton M
PLoS One; 2013; 8(4):e61480. PubMed ID: 23613860
[TBL] [Abstract][Full Text] [Related]
19. The MNN2 Gene Knockout Modulates the Antifungal Resistance of Biofilms of Candida glabrata.
Rodrigues CF; Vilas Boas D; Haynes K; Henriques M
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30380780
[No Abstract] [Full Text] [Related]
20. Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole.
Siscar-Lewin S; Gabaldón T; Aldejohann AM; Kurzai O; Hube B; Brunke S
mBio; 2021 Jun; 12(3):e0112821. PubMed ID: 34061590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
